Skip to main content

Elite Running Tied to Longer Life Expectancy

Medically reviewed by Carmen Pope, BPharm. Last updated on May 14, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, May 14, 2024 -- Sub-four-minute mile runners have greater longevity than the general population, with results dating back as far as the 1950s, according to a study published online May 10 in the British Journal of Sports Medicine.

Stephen Foulkes, Ph.D., from Integrated Cardiovascular Exercise Physiology and Rehabilitation Laboratory at the University of Alberta in Edmonton, Canada, and colleagues used the Sub-4 Alphabetic Register to identify the first 200 athletes (100 percent male) to run a sub-four-minute mile and to examine associations with longevity.

The researchers found that 60 were deceased and 140 were still alive. Overall, sub-four-minute mile runners lived an average of 4.7 years beyond their predicted life expectancy. Longevity benefits were 9.2 years for completion in the 1950s, 5.5 years for completion in the 1960s, and 2.9 years for completion in the 1970s.

"To the best of our knowledge, this study represents the largest report of the longevity of runners to successfully run one mile in under four minutes. Whether such an elite feat has consequences for health and longevity is an important question," the authors write. "In studying the longevity of the first 200 four-minute mile runners we show that they have a longer lifespan than the general population and, as a corollary, our analysis shows that breaking previously conceived boundaries of running physiology does not come at the cost of a shortened lifespan."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals

TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study...

One in Nine U.S. Children Have Ever Been Diagnosed With ADHD

THURSDAY, May 23, 2024 -- Diagnoses of attention-deficit/hyperactivity disorder (ADHD) in U.S. children continue to increase, with approximately one in nine having ever received a...

2024 ASCO Annual Meeting to Focus on Clinical Cancer Research Impacting Patient Care

THURSDAY, May 23, 2024 -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held May 31 to June 4, 2024, in Chicago and online. The theme of this...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.